Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000038

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Michael Scott Mann
Officer — President · Director
Period of report
Apr 18, 2017
Accepted (ET)
Apr 21, 2017 · 11:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
common StockApr 18, 2017P1,000$0.0646A20,218,849D
common stockApr 18, 2017P1,000$0.0648A20,219,849D
common stockApr 18, 2017P1,000$0.0648A20,220,849D
common stockApr 18, 2017P1,000$0.065A20,221,849D
commonApr 18, 2017P1,000$0.063A20,222,849D
common stockApr 18, 2017P1,000$0.063A20,223,849D
common stockApr 18, 2017P1,000$0.063A20,224,849D
common stockApr 18, 2017P1,000$0.0625A20,225,849D
common stockApr 18, 2017P1,000$0.0625A20,226,849D
common stockApr 18, 2017P1,000$0.065A20,227,849D
common stockApr 18, 2017P1,000$0.065A20,228,849D
common stockApr 18, 2017P1,000$0.065A20,229,849D
comon stockApr 18, 2017P1,000$0.065A20,230,849D
common stockApr 18, 2017P1,000$0.065A20,231,849D
common stockApr 18, 2017P0$1,000.00A20,232,849D
common stockApr 18, 2017P1,000$0.0619A20,233,849D
common stockApr 18, 2017P1,000$0.065A20,234,849D
common stockApr 18, 2017P1,000$0.0674A20,235,849D
common stockApr 18, 2017P1,000$0.0668A20,236,849D
common stockApr 18, 2017P1,000$0.0689A20,237,849D
common stockApr 18, 2017P1,000$0.07A20,238,849D

Table II — derivative securities

No Table II lines on this filing.